Determination of Calreticulin (CALR) mutation status based on peripheral blood immunohistochemistry and flow cytometry.
Not Applicable
Recruiting
- Conditions
- Myeloproliferative Neoplasms
- Registration Number
- ACTRN12618000362291
- Lead Sponsor
- Dr Andrew Parker
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method